MIES (Switzerland) - The 2025 List of Prohibited Substances and Methods (List) and the 2025 Monitoring Program is now in force as of January 1, 2025. The 2025 List was approved by WADA’s Executive Committee during its meeting on September 12, 2024.
The List is one of the eight International Standards that are mandatory for all Signatories of the World Anti-Doping Code (Code). It designates what substances and methods are prohibited both in- and out-of-competition and which substances are banned in particular sports.
Major modifications for 2025
As outlined in the 2025 Summary of Major Modifications and Explanatory Notes, the major modifications for 2025 include the following:
Further examples were added to the following substance classes to help athletes and their entourage better identify prohibited substances:
S0. Non-approved substances,
S4. Hormone and metabolic modulators,
S5. Diuretics and masking agents, and
S6. Stimulants.
The dosing intervals of formoterol have been changed, though the maximum daily delivered dose remains the same.
Donation of blood and blood components including by apheresis are no longer prohibited if performed in an accredited collection center.
Hydrafinil is now classified as a non-specified stimulant.
It is clarified that guanfacine is not a prohibited substance.
Beta-blockers are no longer prohibited in any skiing and snowboarding disciplines.
Annual list review process
WADA leads an annual revision process concerning the List, beginning with an initial meeting in January and concluding with the publication of the List by October 1. This is an extensive consultation process that includes WADA’s List Expert Advisory Group gathering information including the latest scientific and medical research, trends, and intelligence gathered from law enforcement and pharmaceutical companies; circulating a draft List among stakeholders; and, taking their submissions into consideration to revise the draft, followed by review by the Agency’s Health, Medical and Research (HMR) Committee. The HMR Committee then makes its recommendations to WADA’s ExCo, which approves the List during its September meeting. For more information on the process, click here.
The Therapeutic Use Exemption Program
It should be noted that players who have a legitimate medical reason for using a prohibited substance or method that is on the List can apply for a Therapeutic Use Exemption (TUE) to determine whether they meet the criteria outlined in the International Standard for Therapeutic Use Exemptions (ISTUE). The TUE Program is a rigorous and necessary part of elite sport and has overwhelming acceptance from athletes, physicians, and anti-doping stakeholders.
If a player needs to take a prohibited substance for therapeutic purposes, please fill out and submit FIBA's TUE Application as soon as possible.
Educational Resources
In addition to the documents linked above, WADA has provided educational resources as part of its Code Implementation Support Program (CISP), which can be accessed through the links below and on the Agency’s Anti-Doping Education and Learning Platform (ADEL). These resources include:
A CISP Checklist – Implementing Revised List (available now - originally published January 2021)
Athlete and ASP Guide to the 2025 List (available now)
Languages and Formats
The 2025 Prohibited List, the 2025 Summary of Modifications and Explanatory Notes, and the 2025 Monitoring Program are available for download on WADA’s website in English, French, and Spanish, as well as a mobile-friendly digital edition.
For more details on anti-doping regulations at FIBA, click here.
FIBA